March 2021: The manufacture of isoprenol in Escherichia coli has recently been established using synthetic microbial systems using the heterologous mevalonate pathway, and a large yield and titer improvement has been accomplished via a decade of research.
August 10, 2023: A new licence arrangement between Santa Cruz Biotechnology Inc. and ERS Genomics Limited was announced. Through this non-exclusive licence, SCBT will have access to the ERS CRISPR/Cas9 patent portfolio.
Author Credits: Smruti Ranjan, Rajrani Baghel
Report ID: 5263
Published Date: Sep 25, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The major factors driving the growth of the market are growing demand for cosmetic products, rise in horticulture activity, and surge in preference for fossil fuel alternative.
The market size of isoprenol is anticipated to attain a CAGR of 6.1% over the forecast period, i.e., 2023 â€“ 2035.
The major players in the market are Spectrum Chemical, Toronto Research Chemicals, Nanjing Chemical Material Corp, NHU. Zhejiang, and others.
The reagent grade segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.